Trials / Recruiting
RecruitingNCT07143695
Parasternal Intercostal Muscle Thickening as an Additive Weaning Criterion
Parasternal Intercostal Muscle Thickening as an Additive Weaning Criterion to Minimize Re-intubation Rate: a Randomized Controlled Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Increased days of MV are not without hazards, including barotraumas and ventilator-associated pneumonia. Similarly, premature separation of MV is associated with increased mortality secondary to adverse cardiorespiratory events. Therefore, the time of weaning should be wisely evaluated. There is growing evidence concerning respiratory muscles dysfunction that contributes to difficulty or prolonged liberation from MV.
Detailed description
Researchers aim to evaluate the influence of adding parasternal thickening fraction to the standard weaning criteria and its impact on reintubation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Parasternal intercostal thickening fraction | Parasternal intercostal thickening fraction less than 6.5% |
| DEVICE | Sham parasternal intercostal thickening | Ultrasound assessment only for purpose of blinding |
Timeline
- Start date
- 2025-09-01
- Primary completion
- 2026-08-01
- Completion
- 2026-08-31
- First posted
- 2025-08-27
- Last updated
- 2025-09-08
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07143695. Inclusion in this directory is not an endorsement.